Trade Summary

1 week ago, Bergstrom Donald A, serving as President, R&D at Relay Therapeutics, Inc. (RLAY), sold 2,237 shares at $18.61 per share, for a total transaction value of $41,630.57. Following this transaction, Bergstrom Donald A now holds 407,660 shares of RLAY.

This sale represents a 0.55% decrease in Bergstrom Donald A's stake in the company.

The trade was executed on Tuesday, July 28, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, July 30, 2026 at 4:12 PM ET, 2 days after the trade was made.

Relay Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.